PanNAT™ Molecular Diagnostic Platform

Micronics’ PanNAT™ molecular diagnostic platform is a convenient, battery and / or mains powered instrument capable of processing distinct cartridges, each designed to perform a single and /or multiplexed nucleic acid amplification assay.  Each assay is fully integrated into the disposable cartridge that includes all necessary reagents. Only a small volume of biological sample is required for assay performance.

The PanNAT system provides a sample on – result off answer in as little as 30 minutes, with no sample preparation required. The platform is uniquely configured for use in decentralized environments and offers full connectivity.

Micronics is advancing the PanNAT system with a focus on point of care infectious disease diagnosis. Infectious diseases account for over 25% of all diseases worldwide.  Rapid and accurate point of care diagnosis of infectious diseases would not only greatly improve potential outcomes of interventions, but also play a major role in the prevention of the spread of these diseases.

PanNAT assays currently in development:

• PanNAT Malaria Assay:  Detects all species that cause Malaria; differentiates P. falciparum from fingerstick whole blood sample
  
  
• PanNAT STEC (Shiga Toxin-producing E. coli) Assay: Detects Shiga toxin I and II, differentiates E.coli O157:H7 serotype directly from diarrheal stool sample